December 11, 2021
2 min watch
Save
VIDEO: Cardiovascular risk factors associated with JAK inhibitor use in RA
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video from ACR Convergence 2021, Kathryn Dao, MD, highlighted cardiovascular risk factors to be aware of when prescribing JAK inhibitors for patients with rheumatoid arthritis.
Dao, associate professor in the department of internal medicine’s division of rheumatology at UT Southwestern Medical Center, discussed two presentations. One was an oral surveillance of risk factors, while the other collected real-world data. Both reported similar conclusions.
“I thought that was really interesting,” she said. “It can help dictate your practice.”
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Dao reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.